Skip to main content
. 2021 Feb 2;11:616450. doi: 10.3389/fimmu.2020.616450

Figure 1.

Figure 1

Patient inclusions between December 2017 and September 2020. DR, drug-resistant; DS, drug-susceptible; LTFU, lost to follow-up. TB, tuberculosis. HIV, human immunodeficiency virus. Treatment for DS-TB patients lasted 6 months. Treatment for DR-TB patients lasted 9 to 24 months.